glp 1 mash Resmetirom and GLP-1 agonists for MASH: complementary rather than exclusive Semaglutide targets MASH molecular pathways

Here are the four we recommend.

A population-based cohort study of nearly 114,000 patients with T2D found that use of GLP-1s, compared with SGLT-2 inhibitors, was associated with a 27% higher relative risk of being diagnosed with GERD and a 55% higher relative risk of GERD-related complications

They work by mimicking the effects of the naturally occurring hormone called glucagon-like peptide-1 (GLP-1), which is responsible for regulating insulin and blood sugar levels

As their popularity continues to rise, employers face a unique set of opportunities and challenges, particularly regarding cost management and employee wellbeing

PlexusDx offers compounded semaglutide injections starting at $149/month to support joint health alongside metabolic wellness

Pfizers dose-optimization studies of once-daily formulations of danuglipron ( NCT06567327 and NCT06568731 ) met key pharmacokinetic objectives and confirmed a formulation and dose with the potential to deliver a competitive efficacy and tolerability profile in Phase 3 testing, based on earlier studies of twice-daily danuglipron